Skip to the page

Data / Drug companies / Naloxone hydrochloride

Naloxone hydrochloride: 40 companies and 80 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Naloxone hydrochloride is listed in the FDA National Drug Code Directory by 40 companies, with 80 products in commercial distribution. 73 of the products (91.2%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; spray; injection, and the newest product started marketing on October 28, 2026.

The request: Get every company that lists naloxone hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
40
Products
80
Generic (ANDA) products
73 (91.2%)
Application numbers
29
Routes
Intramuscular, Subcutaneous, Intravenous, Nasal, Parenteral
Brand names
Narcan, Narcan, Rextovy, Zimhi, RiVive
openFDA record search
api.fda.gov

Companies that list naloxone hydrochloride

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
HF Acquisition Co LLC, DBA HealthFirst11injection, solution; injectionGeneric drugs (ANDA)July 30, 2023
Medical Purchasing Solutions, LLC8injection, solution; injectionGeneric drugs (ANDA)January 29, 2021
A-S Medication Solutions5spray; injection, solutionGeneric drugs (ANDA)July 30, 2023
International Medication Systems, Limited4injection; sprayGeneric drugs (ANDA)May 7, 2024
Eugia US LLC3injection, solutionGeneric drugs (ANDA)January 14, 2021
Henry Schein, Inc.3injection, solution; injectionGeneric drugs (ANDA)October 28, 2025
Hospira, Inc.3injection, solutionGeneric drugs (ANDA)September 23, 2005
Mylan Institutional LLC3injection, solutionGeneric drugs (ANDA)December 2, 2022
Baxter Healthcare Corporation2injection, solutionGeneric drugs (ANDA)November 7, 2022
Fresenius Kabi USA, LLC2injection, solutionGeneric drugs (ANDA)April 2, 2024
Hikma Pharmaceuticals USA Inc.2injectionGeneric drugs (ANDA)July 25, 2025
Lifestar Pharma LLC2injection, solutionGeneric drugs (ANDA)February 19, 2026
ProPharma Distribution2injection, solutionGeneric drugs (ANDA)August 8, 2017
Proficient Rx LP2sprayNew drug applications (NDA)June 21, 2022
Remedyrepack Inc.2injection; injection, solutionGeneric drugs (ANDA)October 28, 2026
Somerset Therapeutics, LLC2injection, solutionGeneric drugs (ANDA)August 8, 2017
Actavis Pharma, Inc.1spray, meteredGeneric drugs (ANDA)January 17, 2025
Advanced Rx of Tennessee, LLC1sprayGeneric drugs (ANDA)June 27, 2024
Amerisource Bergen1sprayGeneric drugs (ANDA)March 12, 2025
Amneal Pharmaceuticals NY LLC1sprayGeneric drugs (ANDA)April 24, 2024
Asclemed USA, Inc.1spray, meteredGeneric drugs (ANDA)September 23, 2024
AvKARE1sprayGeneric drugs (ANDA)May 1, 2024
Baxter Healthcare Corporation1injection, solutionGeneric drugs (ANDA)June 3, 2025
BluePoint Laboratories1sprayGeneric drugs (ANDA)May 1, 2025
Bpi Labs LLC1injection, solutionGeneric drugs (ANDA)November 15, 2023
Bryant Ranch Prepack1sprayGeneric drugs (ANDA)July 30, 2023
CVS Woonsocket Prescription Center, Incorporated1sprayGeneric drugs (ANDA)April 24, 2024
Dr. Reddy's Laboratories Inc.1injectionGeneric drugs (ANDA)March 18, 2020
Emergent Devices Inc.1sprayNew drug applications (NDA)January 24, 2017
Harm Reduction Therapeutics, Inc.1sprayNew drug applications (NDA)January 2, 2024
Kaleo, Inc1injection, solutionNew drug applications (NDA)February 28, 2022
NorthStar RxLLC1injection, solutionGeneric drugs (ANDA)July 1, 2024
Padagis Israel Pharmaceuticals Ltd1sprayGeneric drugs (ANDA)July 30, 2023
Par Health USA, LLC1injectionGeneric drugs (ANDA)November 5, 2024
Sina Health Inc1injection, solutionGeneric drugs (ANDA)August 8, 2017
Sportpharm LLC1spray, meteredGeneric drugs (ANDA)September 23, 2024
Strategic Sourcing Services LLC1sprayGeneric drugs (ANDA)April 1, 2025
Teva Pharmaceuticals, Inc.1spray, meteredGeneric drugs (ANDA)September 23, 2024
Walgreen Company1sprayGeneric drugs (ANDA)April 24, 2024
Zmi Pharma Inc.1injection, solutionNew drug applications (NDA)January 15, 2022

Dosage forms

Dosage formProductsShare
Injection, solution4252.5%
Spray1923.8%
Injection1518.8%
Spray, metered45%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)7391.2%
New drug applications (NDA)78.8%

Pharmacologic classes

ClassProducts
Opioid Antagonist80

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.